Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Darsow

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Acta Haematologica|January 1, 1984
Mitochondrial changes in malignant lymphoma cellsD Huhn, G Wochinger, M Darsow
Oncology Reports|February 19, 1999
P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-stainingO J Stoetzer, R Munker, M Darsow, et al.
Annals of Hematology|July 1, 1992
TNF induces cytoplasmic vesicles in actinomycin D-treated K 562 cellsR Munker, L Greither, M Darsow, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 15, 1994
[Expression of transforming growth factor beta-3 (TGF-beta-3) on reactive and malignant cells in ascites and pleural effusion]R Munker, M Darsow, O Stötzer, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 1996
Autoantibodies against p53 are not increased in human ascites and pleural effusionsR Munker, O Stötzer, M Darsow, et al.
Anticancer Research|September 2, 1999
Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusionsR Lamerz, O J Stoetzer, J Mezger, et al.
Acta Haematologica|January 1, 1993
Effects of tumor necrosis-factor on primary human leukemia cells: ultrastructural changesR Munker, L Greither, M Darsow, et al.
Leukemia|July 1, 1996
Association of bcl-2, bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemiaO J Stoetzer, V Nüssler, M Darsow, et al.
Leukemia|November 11, 1999
Drug-induced apoptosis in chronic lymphocytic leukemiaO J Stoetzer, A Pogrebniak, M Scholz, et al.
Breast Cancer Research and Treatment|February 24, 2001
Long-term morbidity following axillary dissection in breast cancer patients--clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factorsT Kuehn, W Klauss, M Darsow, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Acta Haematologica|January 1, 1984
Mitochondrial changes in malignant lymphoma cellsD Huhn, G Wochinger, M Darsow
Oncology Reports|February 19, 1999
P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-stainingO J Stoetzer, R Munker, M Darsow, et al.
Annals of Hematology|July 1, 1992
TNF induces cytoplasmic vesicles in actinomycin D-treated K 562 cellsR Munker, L Greither, M Darsow, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 15, 1994
[Expression of transforming growth factor beta-3 (TGF-beta-3) on reactive and malignant cells in ascites and pleural effusion]R Munker, M Darsow, O Stötzer, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 1996
Autoantibodies against p53 are not increased in human ascites and pleural effusionsR Munker, O Stötzer, M Darsow, et al.
Anticancer Research|September 2, 1999
Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusionsR Lamerz, O J Stoetzer, J Mezger, et al.
Acta Haematologica|January 1, 1993
Effects of tumor necrosis-factor on primary human leukemia cells: ultrastructural changesR Munker, L Greither, M Darsow, et al.
Leukemia|July 1, 1996
Association of bcl-2, bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemiaO J Stoetzer, V Nüssler, M Darsow, et al.
Leukemia|November 11, 1999
Drug-induced apoptosis in chronic lymphocytic leukemiaO J Stoetzer, A Pogrebniak, M Scholz, et al.
Breast Cancer Research and Treatment|February 24, 2001
Long-term morbidity following axillary dissection in breast cancer patients--clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factorsT Kuehn, W Klauss, M Darsow, et al.
Pageof 2